Claybrook Capital, LLC
- SEC CIK
- 0001729848
- Latest filing
- Oct 24, 2023
CSTL holding history
Castle Biosciences Inc in every 13F filed by Claybrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CSTL overviewAll 13F holders of CSTLFull Q3 2023 holdings
- Shares (Q3 2023)
- 10,026
- Value
- $169.3K
- % of portfolio
- 0.1%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 10,026 | $169.3K | 0.1% | −3,500−25.9% | Reduced | Holders |
| Q2 2023 | 13,526 | $185.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 13,526 | $307.3K | 0.2% | +3,500+34.9% | Added | Holders |
| Q4 2022 | 10,026 | $236.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 10,026 | $261.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2022 | 10,026 | $220.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 10,026 | $450.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2021 | 10,026 | $430.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2021 | 10,026 | $667.0K | 0.3% | +10,026 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −10,026−100.0% | Sold out | Holders |
| Q1 2021 | 10,026 | $686.0K | 0.4% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.